← Evidence map

TrialNeurology2014

Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Onajite Kousin-Ezewu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24838790